Zydus Lifesciences

Gujarat second richest as per Hurun List 2025

After Gautam Adani, this pharma billionaire is richest in Gujarat; his net worth is Rs 84,510 crore

The pharmaceutical leader is also positioned fourth among India’s top five pharma entrepreneurs, trailing only Cyrus Poonawalla, Dilip Shanghvi, and…

Updated: October 12, 2025 14:27 IST

Hospital stocks surge: Apollo Hospitals, Max Healthcare, Fortis soar 5% on CGHS overhaul

From Hero MotoCorp, United Spirits, IndiGo to TVS Motor – Here are 10 stocks to watch

Stocks to watch today, October 03: GIFT Nifty indicates a muted start for domestic indices. Here are the top stocks…

October 3, 2025 06:29 IST

orporate announcements, stock market news, stock market India September 22

From IT stocks, Zydus Lifesciences to Oil India – Here are 10 stocks to watch today

Track key stocks today including IT, Zydus Lifesciences, Oil India, and more amid major corporate developments—see which shares to watch!

September 22, 2025 06:34 IST

3 Indian MedTech stocks powering a Rs 4.4 lakh crore opportunity

India’s MedTech sector is rapidly growing due to supportive government policies like the PLI scheme, fostering indigenous manufacturing. Key players…

September 17, 2025 05:10 IST

Zydus Wellness’s big bet on Europe: A smart move or a costly gamble?

Zydus Wellness’ acquisition of UK-based Comfort Click will give it an entry into the fast growing vitamins, minerals and supplements…

September 4, 2025 05:15 IST

From Indus Towers, TCS, JSW Cement to Yes Bank- Here are 12 stocks to watch

Stocks to watch today, September 03: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…

September 3, 2025 06:24 IST

Zydus launches India’s first trivalent influenza vaccine VaxiFlu for seasonal flu protection

Zydus Lifesciences has launched VaxiFlu, India’s first trivalent influenza vaccine for seasonal flu protection. The vaccine follows WHO’s 2025–26 guidelines…

September 2, 2025 15:41 IST

Trump tariff on India, pharma sector impact, Indian pharma exports

Trump tariff impact on Pharma: Breathing easy or trapped in crosshair ahead? Here’s how stocks are reacting

Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what…

July 31, 2025 10:59 IST

Nuvoco Vistas share price, Nuvoco stock rating

Market watchlist: Tata Steel, JSW Steel, Cipla among 9 stocks in spotlight; FIIs turn bearish on earnings jitters

Markets remain cautious ahead of earnings; track Tata Steel, JSW Steel, and Cipla for breakout moves this week.

July 7, 2025 05:30 IST

Related News

Four big companies have now stopped sponsoring H-1B visas. Here is the full list

From H-1B to green card: Follow the journey of an Indian entrepreneur to $3.7 billion

Indian techie overcomes H-1B challenges, gets green card, quits job, and achieves $3.7 billion success

Richest Man in Pune, Cyrus Poonawalla with $21.5 billion net worth, leads a luxurious lifestyle with palatial homes, impressive car collection

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar card update new rules from November 2025: You won’t need to upload documents anymore — here’s how to change your details online

Asia Cup Trophy Controversy: India refuses award, PCB proposes special handover

Asia Cup 2025 Trophy row: PCB chief Mohsin Naqvi sends firm message to BCCI, says ‘If you want the trophy, we…’

Jio pivoting from mobile growth to home broadband play: Analysts

Business58 min ago

Reliance Jio’s Q2 results showed a shift towards home connectivity, with 8.3 million new users and a total of 506 million subscribers. Fixed broadband and 5G net additions were at 2.4 million and 21 million respectively. FWA and FTTH net adds were 2.1 million and 0.9 million, indicating the success of Jio’s home broadband expansion.

View all shorts